tiprankstipranks
Trending News
More News >
Comera Life Sciences Holdings (CMRA)
OTHER OTC:CMRA
US Market

Comera Life Sciences Holdings (CMRA) Income Statement

Compare
26 Followers

Comera Life Sciences Holdings Income Statement

Last quarter (Q3 2023), Comera Life Sciences Holdings's total revenue was $136.31K, a decrease of -41.98% from the same quarter last year. In Q3, Comera Life Sciences Holdings's net income was $-2.15M. See Comera Life Sciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20
Total Revenue
$ 633.10K$ 319.83K$ 442.92K
Gross Profit
$ 422.71K$ 158.82K$ 338.51K
Operating Expenses
$ 12.39M$ 5.69M$ 2.47M
Depreciation and Amortization
$ 93.95K$ 86.14K$ 89.75K
EBITDA
$ -17.89M$ -5.37M$ -2.04M
Operating Income
$ -11.97M$ -5.54M$ -2.13M
Other Income/Expenses
$ -6.03M$ 83.85K$ 2.03K
Pretax Income
$ -18.00M$ -5.45M$ -2.13M
Net Income
$ -18.00M$ -5.45M$ -2.13M
Per Share Metrics
Basic EPS
$ -1.76$ -0.29$ -0.11
Diluted EPS
$ -1.76$ -0.29$ -0.11
Weighted Average Shares Outstanding
10.45M 19.09M 19.09M
Weighted Average Shares Outstanding (Diluted)
10.45M 19.09M 19.09M
Currency in USD

Comera Life Sciences Holdings Earnings and Revenue History